V

ViroGates A/S
CSE:VIRO

Watchlist Manager
ViroGates A/S
CSE:VIRO
Watchlist
Price: 11.9 DKK -1.65% Market Closed
Market Cap: 92.1m DKK
Have any thoughts about
ViroGates A/S?
Write Note

ViroGates A/S
Investor Relations

ViroGates A/S develops and markets prognostic products for the healthcare sector. Its develops a product line suPARnostic, which measures the amount of amount of soluble urokinase Plasminogen Activator Receptor protein (suPAR) in human blood. The plasma level of suPAR reflects immune activation and is increased in such infectious diseases as HIV-1-infection, malaria, tuberculosis, Streptococcus pneumonia bacteraemia, sepsis, pneumococcal pneumonia and bacterial and viral CNS infection. Also, high suPAR levels are associated with increased inflammation, disease progression and risk of mortality. Thus, measuring suPAR levels serves as a marker to determine chances for survival upon hospital admission, as well as for monitoring for prevention of disease progression and earlier intervention time point. suPARnostic has two versions: Quantitative Point of Care Quick Triage test, which serves for patient triage in acute care, and Quantitative ELISA Assay that aims at clinical routine use.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Jakob Knudsen
Chief Executive Officer
No Bio Available
Dr. Jesper Eugen-Olsen
Co-Founder & Chief Scientific Officer
No Bio Available
Ms. Josephine Baum Jorgensen
Chief Financial Officer
No Bio Available
Ms. May Britt Dyvelkov
Vice President of Accounting
No Bio Available
Mr. Thomas Krarup
Vice President of Global Sales & Marketing
No Bio Available
David Stig Poulsen
Head of Marketing
No Bio Available

Contacts

Address
Birkeroed
Banevaenget 13
Contacts